Phytoestrogens and inhibition of angiogenesis

Bailliere's Clinical Endocrinology and Metabolism

Volumn 12, Issue 4, 1998, Pages 649-666

  Fotsis, T ^a   Pepper, M S ^a   Montesano, R ^a   Aktas, E ^a   Breit, S ^a   Schweigerer, L ^a   Rasku, S ^a   Wahala, K ^a   Adlercreutz, H ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Angiogenesis; Diet; Flavonoids; Genistein; Inhibition; Isoflavonoids; Proliferation

Indexed keywords

3 HYDROXYFLAVONE; 3',4' DIHYDROXYFLAVONE; APIGENIN; FISETIN; GENISTEIN; ISOFLAVONOID; LUTEOLIN; PHYTOESTROGEN; UNCLASSIFIED DRUG;

ANGIOGENESIS; CANCER GROWTH; CELL PROLIFERATION; CHRONIC DISEASE; CONCENTRATION RESPONSE; DIET; NEOVASCULARIZATION (PATHOLOGY); REVIEW; TUMOR CELL;

EID: 0032466866     PISSN: 0950351X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-351X(98)80009-8     Document Type: Article

References (56)

1. Adlercreutz H. Western diet and western diseases: some hormonal and biochemical mechanisms and associations Scandinavian Journal of Clinical and Laboratory Investigation 50 supplement 201 1990 3 23
2. Adlercreutz H. Fotsis T. Bannwart C. Isotope dilution gas chromatographic-mass spectrometric method for the determination of lignans and isoflavonoids in human urine including identification of genistein Clinica Chimica Acta 199 1991 263 278
3. Adlercreutz H. Honjo H. Higashi A. Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming traditional Japanese diet American Journal of Clinical Nutrition 54 1991 1093 1100
4. Adlercreutz H. Van der Wildt J. Kinzel J. Lignan and isoflavonoid conjugates in human urine Journal of Steroid Biochemistry and Molecular Biology 52 1995 97 103
5. Akiyama T. Ishida J. Nakagawa S. Genistein a specific inhibitor of tyrosine-specific protein kinases Journal of Biological Chemistry 262 1987 5592 5595
6. De Azevedo W.F. Mueller-Dieckmann H.J. Schulze-Gahman U. Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2 a cell cycle kinase Proceedings of the National Academy of Sciences of the USA 93 1996 2735 2740
7. Boege F. Straub T. Kehr A. Selected novel flavones inhibit the DNA binding or the DNA religation step of eukaryotic topoisomerase I Journal of Biological Chemistry 271 1996 2262 2270
8. Carlson B.A. Bubay M.M. Sausville E.A. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK)2 and CDK4 in human breast carcinoma cells Cancer Research 56 1996 2473 2478
9. Crum R. Szabo S. Folkman J. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment Science 230 1985 1375 1378
10. Cunningham B.D.M. Threadgill M.D. Groundwater P.W. Synthesis and biological evaluation of a series of flavones designed as inhibitors of protein tyrosine kinases Anti-Cancer Drug Design 7 1992 365 384
11. Das A. Wang J.H. Lien E.J. Carcinogenicity mutagenicity and cancer preventing activities of flavonoids: a structure-system-activity relationship (SSAR) analysis Jucker E. Progress in Drug Research 1995 Birkhaeuser Verlag Basel 133 166
12. Denekamp J. Vascular attack as a therapeutic strategy for cancer Cancer Metabolism Review 9 1990 267 282
13. Devasagayam T.P. Subramanian M. Singh B.B. Protection of plasmid pBR322 DNA by flavonoids against single-stranded breaks induced by singlet molecular oxygen Journal of Photochemistry and Photobiology 30 1995 97 103
14. Elangovan V. Sekar N. Govindasamy S. Chemopreventive potential of dietary bioflavonoids against 20-methylcholanthrene-induced tumorigenesis Cancer Letters 87 1994 107 113
15. Ferriola P.C. Cody V. Middleton E.J. Protein kinase C inhibition by plant flavonoids Biochemical Pharmacology 38 1989 1617 1624
16. Folkman J. Tumor angiogenesis Advances in Cancer Research 43 1985 175 203
17. Folkman J. Cotran R.S. Relation of vascular proliferation to tumor growth International Review of Experimental Pathology 16 1976 207 248
18. Folkman J. Klagsbrun M. Angiogenic factors Science 235 1987 442 447
19. Fotsis T. The multicomponent analysis of estrogens in urine by ion exchange chromatography and GC-MS-II. Fractionation and quantitation of the main group of estrogen conjugates Journal of Steroid Biochemistry 28 1987 215 226
20. Fotsis T. Adlercreutz H. The multicomponent analysis of estrogens in urine by ion exchange chromatography and GC-MS-I. Quantitation of estrogens after initial hydrolysis ofconjugates Journal of Steroid Biochemistry 28 1987 203 213
21. Fotsis T. Pepper M. Adlercreutz H. Genistein a dietary-derived inhibitor of in vitro angiogenesis Proceedings of the National Academy of Sciences of the USA 90 1993 2690 2694
22. (supplement) Fotsis T. Pepper M. Adlercreutz H. Genistein a dietary ingested isoflavonoid inhibits cell proliferation and in vitro angiogenesis Journal of Nutrition 125 1995 790S 797S
23. Fotsis T. Pepper M.S. Aktas E. Flavonoids dietary-derived inhibitors of cell proliferation and in vitro angiogenesis Cancer Research 57 1997 2916 2921
24. Graziani Y. Erikson E. Erikson R.L. The effect of quercetin on the phosphorylation activity of the Rous sarcoma virus transforming gene product in vitro and in vivo European Journal of Biochemistry 135 1983 583 589
25. Hanahan D. Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 1996 353 364
26. Harborne J.B. Flavonoids Miller L.P. Phytochemistry 1973 Van Nostrand Reinhold New York 344 380
27. Harborne J.B. Marby T.J. The Flavonoids: Advances in Research 1982 Chapman & Hall London
28. Havsteen B. Flavonoids a class of natural products of high pharmacological potency Biochemical Pharmacology 32 1983 1141 1148
29. Hertog M.G. Hollman P.C. Katan M.B. Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands Nutrition in Cancer 20 1993 21 29
30. Hill T.D. Dean N.M. Mordan L.J. PDGF-induced activation of phospholipase C is not required for induction of DNA synthesis Science 248 1990 1660 1663
31. Hirano T. Abe K. Gotoh M. Oka K. Citrus flavone tangeretin inhibits leukemic HL-60 cell growth partially through induction of apoptosis with less cytotoxicity on normal lymphocytes British Journal of Cancer 72 1995 1380 1388
32. Huang H.C. Wang H.R. Hsieh L.M. Antiproliferative effect of baicalein a flavonoid from a Chinese herb on vascular smooth muscle cell European Journal of Pharmacology 251 1994 91 93
33. Huang Y.T. Kuo M.L. Liu J.Y. Inhibitions of protein kinase C and proto-oncogene expressions in NIH 3T3 cells by apigenin European Journal of Cancer 32A 1996 146 151
34. Ingber D.E. Fujita T. Kishimoto S. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth Nature 348 1990 555 557
35. Kandaswami C. Perkins E. Soloniuk D.S. Antiproliferative effects of citrus flavonoids on a human squamous cell carcinoma in vitro Cancer Letters 56 1991 147 152
36. Klagsbrun M. Folkman J. Angiogenesis Sporn M.B. Roberts A.B. Peptide Growth Factors and their Receptors, II 1990 Springer Verlag Berlin 549 586
37. Kolonel L.N. Variability in diet and its relation to risk in ethnic and migrant groups Basic Life Science 43 1988 129 135
38. Lee H.P. Courley L. Duffy S.W. Dietary effects on breast cancer risk in Singapore Lancet 337 1991 1197 1200
39. Liotta L.A. Steeg P.S. Sterler-Stevenson W.G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation Cell 64 1991 327 336
40. Losiewicz M.D. Carlson B.A. Kaur G. Potent inhibition of CDC2 kinase activity by the flavonoid L86-8275 Biochemical and Biophysical Research Communications 201 1994 589 595
41. Middleton E. Jr. Some biological properties of plant flavonoids Annals of Allergy 61 1988 53 57
42. Miksicek R.S. Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor Journal of Steroid Biochemistry and Molecular Biology 43 1994 153 160
43. Miksicek R.J. Estrogenic flavonoids: structural requirements for biological activity Proceedings of the Society of Experimental Biology and Medicine 208 1995 44 50
44. Miller A.B. Diet and cancer—a review Review of Oncology 3 1990 87 95
45. Montesano R. Orci L. Tumor-promoting phorbol esters induce angiogenesis in vitro Cell 42 1985 469 477
46. Montesano R. Vassalli J.-D. Baird A. Basic fibroblast growth factor induces angiogenesis in vitro Proceedings of the National Academy of Sciences of the USA 83 1986 7297 7301
47. Montesano R. Pepper M.S. Belin D. Induction of angiogenesis in vitro by vanadate, an inhibitor of phosphotyrosine phosphatases Journal of Cell Physiology 134 1988 460 466
48. Pepper M.S. Montesano R. Proteolytic balance and capillary morphogenesis Cell Differentiation and Development 32 1990 319 328
49. Pepper M.S. Ferrara N. Orci L. Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro Biochemical and Biophysical Research Communication 189 1992 824 831
50. Rose D.P. Boyar A.P. Wynder E.L. International comparison of mortality rates for cancer of the breast ovary prostate and colon and per capita fat consumption Cancer 58 1986 2363 2371
51. Schweigerer L. Breit S. Wenzel A. Augmented MYCN expression advances the malignant phenotype of human neuroblastoma cells: evidence for induction of autocrine growth activity Cancer Research 50 1990 4411 4416
52. Schweigerer L. Christeleit K. Fleischmann G. Identification in human urine of a natural growth inhibitor for cells derived from solid pediatric tumors European Journal of Clinical Investigation 22 1992 260 264
53. Shutt D.A. The effects of plant estrogens on animal reproduction Endeavour 35 1976 110 113
54. Singhal R.L. Yeh Y.A. Praja N. Quercetin down-regulates signal transduction in human breast carcinoma cells Biochemical and Biophysical Research Communications 208 1995 425 431
55. Ullrich A. Schlesinger J. Signal transduction by receptors tyrosine kinase activity Cell 61 1990 203 212
56. Yit C.C. Das N.P. Cytotoxic effect of butein on human colon adenocarcinoma cell proliferation Cancer Letters 82 1994 65 72